Loading…
Loading…
AlphaGrep UK Ltd purchased a new stake in shares of Westlake Corporation (NYSE: WLK) during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 12,289 shares of the specialty chemicals company's stock, valued at approximately $897,000. Several other large investors have also
Westlake (WLK) reported earnings 30 days ago. What's next for the stock?
Canada Pension Plan Investment Board bought a new stake in shares of Westlake Corporation (NYSE: WLK) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 14,210 shares of the specialty chemicals company's stock, valued at approximately $1,037,000. Several other hedge funds and other
WLK's HIP growth and acquisitions support its portfolio, but housing weakness, operational risks and global pressures cloud the outlook.
HOUSTON, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Westlake Corporation (NYSE: WLK) (“Westlake”) (the “Company”) announced today the dual listing of its common stock on the NYSE Texas, the newly launched fully electronic equities exchange headquartered in Dallas, Texas. “We are pleased to join the NYSE Texas.
AUSTIN, Texas, Aug. 18, 2026 /PRNewswire/ -- Westlake Securities ("Westlake"), a leading middle-market investment bank, is pleased to announce that it served as exclusive financial advisor to SolvChem, Inc. ("SolvChem" or the "Company") in securing an expanded senior credit facility from Amegy Bank, a division of Zions Bancorporation, N.A., to support the Company's continued growth.
HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Westlake Corporation (NYSE: WLK) today declared a regular dividend distribution of $0.533 per share for the second quarter of 2026. This dividend will be payable on September 10, 2026 to stockholders of record on August 25, 2026.
Assenagon Asset Management S.A. bought a new stake in Westlake Corporation (NYSE: WLK) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 55,289 shares of the specialty chemicals company's stock, valued at approximately $4,036,000. Several other hedge funds also